Effects of high-density lipoprotein particles containing apo A-I, with or without apo A-II, on intracellular cholesterol efflux

This publication has 14 references indexed in Scilit:

• Differential role of apolipoprotein AI-containing particles in cholesterol efflux from adipose cells
  Atherosclerosis, 1991
• High density lipoprotein apolipoproteins mediate removal of sterol from intracellular pools but not from plasma membranes of cholesterol-loaded fibroblasts.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
• Cholesterol efflux from adipose cells is coupled to diacylglycerol production and protein kinase C activation
  Biochemical and Biophysical Research Communications, 1990
• Nonenzymatic glycosylation of HDL resulting in inhibition of high-affinity binding to cultured human fibroblasts
  Diabetes, 1990
• Effect of pravastatin, an HMG CoA reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by their apolipoprotein composition
  Metabolism, 1990
• Downregulation of high density lipoprotein receptor activity of cultured fibroblasts by platelet-derived growth factor.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1987
• Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII particles
  Biochemical and Biophysical Research Communications, 1987
• Regulation of high density lipoprotein binding activity of aortic endothelial cells by treatment with acetylated low density lipoprotein.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1985
• Regulation of high density lipoprotein receptor activity in cultured human skin fibroblasts and human arterial smooth muscle cells.
  Journal of Clinical Investigation, 1983
• Effects of high density lipoprotein subfractions on cholesterol homeostasis in human fibroblasts and arterial smooth muscle cells.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1983